Roche investigating case of patient illness after taking MS drug

ZURICH (Reuters) - A person in Germany treated with Roche’s new multiple sclerosis drug Ocrevus has been diagnosed with an often-deadly brain infection after switching from another medication earlier this year, the Swiss drugmaker said on Wednesday.